BIO-INVESTIGATIONS LTD. - Biotech Consulting, Healthcare Innovation

“Stewart takes a great deal of professional pride in his consulting assignments and puts a great deal of himself into meeting the goals of his clients.”

William E. Griffis

AI Services, Inc.
“Stewart has assisted us in identifying potential commercialization partners, in arranging high-level meetings, and in providing expert advice on commercialization strategy.”

J. M. Curtis

Alberta Research Council
“Jonathan Rosenberg is an individual of high intelligence and polished sales skills, backed by a passion for his work, and a genuinely warm and sincere personality.”

Nate Hollander

American Imaging Inc.
“Your written testimony about your new diagnostic test [for lyme disease] gave all of us much hope for the future of diagnosis and treatment of this difficult illness. I am grateful to you for your participation.”

Richard Blumenthal

State of Connecticut
“The depth and knowledge of experience brought by Bio-lnvestigations Ltd. to this project was very important in a number of areas, including valuation, development of a business strategy and assessment of licence terms.”

Gordon Sustrik

Bennett Jones LLP
“Stewart has been successful in arranging a number of meetings for Binax with high level pharmaceutical executives.”

Roger N. Piasio

Binax Inc.
“His keen awareness of the current business landscape and his vision of future business opportunities inspire confidence.”

Peter M. Meier, Ph.D.

Cuno Corporation
“Apart from the intelligence, very high level of effort and experience that Stewart Rosenberg brings to a task, he also brings a rare ability to grasp the significance of the subtlest scientific phenomenon.”

Myron J. Block

Kromotech
“Stewart's efforts were focused, professional, well thought out and most importantly successful.”

Robert A. Levine

Medical Research and Development
“Mr. Rosenberg successfully arranged a series of telephone conference with senior-level scientific and executive individuals at many of the pre-selected companies.”

Sam Yi

Shanghai Genomics, Inc.

Latest posts from the Journal:

Technology Offering: Side Illuminated Fiber Optics’ (SIFO) Titer Plate Reader Interface (TPRi)

Available 1 January 2023 for: (a) non-exclusive corporate licensing by individual human health care and veterinary IVD manufacturers; (b) potential exclusive license for select health care diagnostic fields of use, or non-exclusive license with ROFN; (c) collaborative research and development agreement, with licensing conversion rights; or (d) exploratory positioning for partnering within environmental, cosmetics, and food industries.

Collaboration with Science & Sensors Technologies on the Commercialization of Side Illuminated Fiber Optic Sensor Technology

1 February 2022: Bio-Investigations Ltd (i.e., “BIO”), headquartered in Madison, CT and Science & Sensors Technologies (i.e., S&ST), headquartered in Los Angeles, CA are pleased to announce their collaboration to commercialize Side Illuminated Fiber Optic Sensor Technology (i.e., “SIFO”). The agreement was executed in...